- Citations, last 5 years
- 142
- Works, last 5 years
- 31
- h-index
- 47
- Scientists listed
- 2
- Grants since 2016
- 7
Grants received
2023–2025 · research · R43
Modulation of Protein S-nitrosylation Signaling as a Potential Therapeutic Breakthrough in Rheumatoid Arthritis
Matthews Ogden Bradley · G1 Therapeutics (United States) · funded by National Institutes of Health
2023–2025 · cooperative agreement · UG3
Development of cebranopadol, a potent dual MOP/NOP agonist, for the treatment of Opioid Use Disorder (OUD)
Roberto Ciccocioppo · G1 Therapeutics (United States) · funded by National Institutes of Health
2021–2024 · research · R43
The Therapeutic Role of GPNMB in Osteoarthritis
Hope Ball · G1 Therapeutics (United States) · funded by National Institutes of Health
2019–2023 · research · R43
Osteoactivin Treatment for Accelerating Spinal Fusion in Osteoporosis
Thomas Siosi Mbimba · G1 Therapeutics (United States) · funded by National Institutes of Health
2017–2025 · research · R44
Amyloid-Beta and Tau/Glycosaminoglycan Dual Inhibitor for Alzheimer's Disease
Paul Gregor · G1 Therapeutics (United States) · funded by National Institutes of Health
2016–2019 · research · R43
Glycosaminoglycan-Interacting Small Molecule (GISMO) as Parkinson's Therapeutic
Paul Gregor · G1 Therapeutics (United States) · funded by National Institutes of Health
2016–2018 · research · R43
Glycosaminoglycan-Interacting Small Molecule (GISMO) as Parkinson's Therapeutic
Paul Gregor · G1 Therapeutics (United States) · funded by National Institutes of Health